Röhm has expanded its production capacity at the Wallingford plant in Connecticut, USA.
Röhm
The innovative improvement was possible by modifying and redeploying an existing production line at the Wallingford site, providing customers with faster delivery and meeting increasing demand globally.
Thomas Spagnuolo, vice president in the Moulding Compounds business unit at Röhm America said: "Röhm is committed to supplying the automotive, medical and other specialty markets with the highest quality products and service offerings, not only in America but also globally."
Polymethyl methacrylate (PMMA) products from Röhm are sold on the European, Asian, African and Australian continent under the registered trademark PLEXIGLAS and in the Americas under the registered trademark ACRYLITE. The Wallingford facility has more than 50 workers and operates several production lines that manufacture specialty PMMA moulding compounds.
“This investment is also part of the growth strategy we have been putting in place and demonstrates our commitment to continuously invest to support our customers in particular with higher quality and regulation standards” said Thom Hemler, global segment director, Medical at Röhm America. The Wallingford site is also a key production site for CYROLITE a transparent, acrylic-based plastic especially for medical applications.
PMMA from Röhm has been established on the market for 90 years and is well-suited for applications where durability, resistance to weather and UV, colour fastness, high luminosity and transparency as well as hardness and scratch-resistance are key. Started as an independent company almost five years ago with the goal of creating the leading Methacrylate Verbund, Röhm is well on its way to achieving this target. The central component of the strategy and the flagship project is the construction of a production plant for methyl methacrylate (MMA) in Bay City, Texas (USA) where the LiMA technology developed by Röhm is used.